Balyasny Asset Management’s Aehr Test Systems AEHR Stock Holding History

Balyasny Asset Management’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$603K	Sell	16,262 -8,513	-34%	-$272K	﹤0.01%	2282
2025 Q4	$500K	Sell	24,775 -4,209	-15%	-$102K	﹤0.01%	2525
2025 Q3	$873K	Buy	+28,984	New	+$628K	﹤0.01%	2169
2025 Q1	–	Sell	-68,714	Closed	-$1.14M	–	2739
2024 Q4	$1.14M	Buy	68,714 +30,991	+82%	+$413K	﹤0.01%	1890
2024 Q3	$485K	Buy	37,723 +23,508	+165%	+$340K	﹤0.01%	2272
2024 Q2	$159K	Buy	+14,215	New	+$166K	﹤0.01%	2372
2024 Q1	–	Sell	-100,984	Closed	-$2.68M	–	2566
2023 Q4	$2.68M	Buy	+100,984	New	+$2.95M	0.01%	1358
2022 Q2	–	Sell	-11,965	Closed	-$122K	–	2703
2022 Q1	$122K	Buy	+11,965	New	+$153K	﹤0.01%	2111

Other funds holding AEHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management's AEHR Position: Q1 2026 in Review

Balyasny Asset Management reduced its Aehr Test Systems (AEHR) stake by 34% in Q1 2026, selling an estimated $272K and leaving 16,262 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #2282.

Balyasny Asset Management first reported a position in AEHR in Q1 2022 and has held it in 8 quarters since. The position peaked at $2.68M in Q4 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

Balyasny Asset Management held 16,262 shares of Aehr Test Systems worth $603K as of Q1 2026.
Balyasny Asset Management sold 8,513 Aehr Test Systems shares in Q1 2026, an estimated $272K.
Aehr Test Systems made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2282 holding.
Balyasny Asset Management first reported a position in Aehr Test Systems in Q1 2022 and has held it in 8 quarters since.
Balyasny Asset Management's Aehr Test Systems position peaked at $2.68M in Q4 2023.
191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.